These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6101830)

  • 41. Functional evaluation of platelet aspirin resistance after on-pump coronary bypass grafting using multiple aggregation tests.
    Kammerer I; Bach J; Saggau W; Isgro F
    Thorac Cardiovasc Surg; 2011 Oct; 59(7):425-9. PubMed ID: 21437867
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rapamycin enhances platelet aggregation induced by adenosine diphosphate in vitro.
    Wu Q; Huang KS; Chen M; Huang DJ
    Platelets; 2009 Sep; 20(6):428-31. PubMed ID: 19639515
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease.
    Capodanno D; Patel A; Dharmashankar K; Ferreiro JL; Ueno M; Kodali M; Tomasello SD; Capranzano P; Seecheran N; Darlington A; Tello-Montoliu A; Desai B; Bass TA; Angiolillo DJ
    Circ Cardiovasc Interv; 2011 Apr; 4(2):180-7. PubMed ID: 21386092
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysing responses to aspirin and clopidogrel by measuring platelet thrombus formation under arterial flow conditions.
    Hosokawa K; Ohnishi T; Sameshima H; Miura N; Ito T; Koide T; Maruyama I
    Thromb Haemost; 2013 Jan; 109(1):102-11. PubMed ID: 23179055
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patients with previous definite stent thrombosis have a reduced antiplatelet effect of aspirin and a larger fraction of immature platelets.
    Würtz M; Grove EL; Wulff LN; Kaltoft AK; Tilsted HH; Jensen LO; Hvas AM; Kristensen SD
    JACC Cardiovasc Interv; 2010 Aug; 3(8):828-35. PubMed ID: 20723855
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rapid platelet inhibition after a single capsule of Aggrenox: challenging a conventional full-dose aspirin antiplatelet advantage?
    Serebruany VL; Malinin AI; Sane DC
    Am J Hematol; 2003 Apr; 72(4):280-1. PubMed ID: 12666142
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of oral aspirin dose on platelet aggregation and arterial prostacyclin synthesis: studies in humans and rabbits.
    Ellis EF; Jones PS; Wright KF; Richardson DW; Ellis CK
    Adv Prostaglandin Thromboxane Res; 1980; 6():313-5. PubMed ID: 6770601
    [No Abstract]   [Full Text] [Related]  

  • 48. Extremely-low-dose aspirin (1 mg per day) renders human platelets more sensitive to antiaggregation prostaglandins.
    Sinzinger H; O'Grady J; Fitscha P; Kaliman J
    N Engl J Med; 1984 Oct; 311(16):1052. PubMed ID: 6384781
    [No Abstract]   [Full Text] [Related]  

  • 49. The differential effect of aspirin on human platelet activation in aspirin-sensitive asthmatics and normal subjects.
    Taylor ML; Stewart GA; Thompson PJ
    Br J Clin Pharmacol; 1993 Mar; 35(3):227-34. PubMed ID: 8471399
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Occasionally patients treated with thrombocyte aggregation inhibition with acetylsalicylic acid also must be treated with non-steroidal antirheumatic drugs].
    Seitz R; Pflüger KH
    Internist (Berl); 1993 Jul; 34(7):689. PubMed ID: 8365862
    [No Abstract]   [Full Text] [Related]  

  • 51. Dose- and time-dependent antiplatelet effects of aspirin.
    Perneby C; Wallén NH; Rooney C; Fitzgerald D; Hjemdahl P
    Thromb Haemost; 2006 Apr; 95(4):652-8. PubMed ID: 16601836
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin.
    Preston FE; Whipps S; Jackson CA; French AJ; Wyld PJ; Stoddard CJ
    N Engl J Med; 1981 Jan; 304(2):76-9. PubMed ID: 7003384
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aspirin: A paradoxical effect on bleeding-time.
    O'Grady J; Moncada S
    Lancet; 1978 Oct; 2(8093):780. PubMed ID: 80698
    [No Abstract]   [Full Text] [Related]  

  • 54. Aspirin with an adrenergic or a calcium-channel-blocking agent as new combination therapy for arterial thrombosis.
    Greer IA; Walker JJ; Calder AA; Forbes CD
    Lancet; 1985 Feb; 1(8424):351-2. PubMed ID: 2857409
    [No Abstract]   [Full Text] [Related]  

  • 55. Eighth Gaddum Memorial Lecture. University of London Institute of Education, December 1980. Biological importance of prostacyclin.
    Moncada S
    Br J Pharmacol; 1982 May; 76(1):3-31. PubMed ID: 7044460
    [No Abstract]   [Full Text] [Related]  

  • 56. The effect of oral phenylbutazone on whole blood platelet aggregation in the dog.
    Jackson ML; Searcy GP; Olexson DW
    Can J Comp Med; 1985 Jul; 49(3):271-7. PubMed ID: 3930056
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Platelets and the vessel wall: how much aspirin?
    O'Brien JR
    Lancet; 1980 Feb; 1(8164):372-3. PubMed ID: 6101830
    [No Abstract]   [Full Text] [Related]  

  • 58. Platelets and the vessel wall: how much aspirin?
    Pareti FI; D'Angelo A; Mannucci PM; Smith JB
    Lancet; 1980 Feb; 1(8164):371-2. PubMed ID: 6101829
    [No Abstract]   [Full Text] [Related]  

  • 59. The utility of thrombo-elastography in the monitoring of aspirin therapy.
    Mayne E; Jacobson B; Louw S; Bernstein P; Mayne A
    S Afr Med J; 2007 Dec; 97(12):1289-91. PubMed ID: 18264612
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aspirin Resistance in Single-Ventricle Physiology: Aspirin Prophylaxis Is Not Adequate to Inhibit Platelets in the Immediate Postoperative Period.
    Mir A; Frank S; Journeycake J; Wolovitis J; Guleserian K; Heistein L; Lemler M
    Ann Thorac Surg; 2015 Jun; 99(6):2158-64. PubMed ID: 25921261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.